Saif, Areeba
Rossi, Alexander J.
Sarnaik, Amod
Hernandez, Jonathan M.
Zager, Jonathan S.
Funding for this research was provided by:
philogen
Article History
Received: 22 November 2021
Accepted: 31 January 2022
First Online: 28 February 2022
Disclosure
: JSZ—Consultant to Philogen, research funding from Philogen. Dr. Sarnaik is a co-inventor on a patent application with Provectus Biopharmaceuticals. Moffitt Cancer Center has licensed intellectual property (IP) related to the proliferation and expansion of tumor infiltrating lymphocytes (TILs) to Iovance Biotherapeutics. Dr. Sarnaik is a co-inventor on such intellectual property. Dr. Sarnaik has received ad hoc consulting fees from Iovance Biotherapeutics, Guidepoint, Defined Health, Huron Consulting Group, KeyQuest Health Inc., Istari, and Gerson Lehrman Group; he has also received speaker fees from Physicians’ Educational Resource (PER) LLC, Medscape, and Medstar Health.